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ABSTRACT
Activation of the transcription factor NF-kB is critical
for the tumor necrosis factor-a (TNF-a)-induced
inflammatory response. Here we report the complete
gene expression profile from activated micro-
vascular endothelial cells emphasizing the direct
contribution of the NF-kB pathway. Human microvas-
cularendothelialcellline-1(HMEC-1)cellsweremodi-
fied to express dominant interfering mutants of the
IKK/NF-kB signaling module and expression profiles
were determined. Our results provide compelling
evidence for the virtually absolute dependence of
TNF-a-regulated genes on NF-kB. A constitutively
active IKK2 was sufficient for maximal induction of
most target genes, whereas a transdominant IkBa
suppressed gene expression. Several genes with a
critical role in atherogenesis were identified. The
endothelial lipase (EL) gene, a key enzyme involved
in lipoprotein metabolism, was investigated more in
detail. Binding sites interacting with NF-kB in vitro
and in vivo were identified and co-transfection
experiments demonstrated the direct regulation of
the EL promoter by NF-kB. We conclude that target-
ing the IKK/NF-kB pathway or specific genes
downstream may be effective for the control or pre-
vention of chronic inflammatory diseases such as
atherosclerosis.
INTRODUCTION
The endothelium is a dynamic organ that provides a structural
and functional barrier between the circulation and the sur-
rounding tissue. The endothelial cell (EC), that forms the
non-thrombogenic lining of the vessels in every organ, rep-
resents a selective semi-permeable barrier that reacts with
physical and chemical stimuli regulating the hemostasis,
vasomotor tone and immune response (1). Endothelial cells
play a pivotal role in inﬂammation, which constitutes the
survey strategy of the innate immune system to thwart most
pathogenic threats. To date much evidence reveals that the
magnitude of the inﬂammatory response is crucial to keep the
organism homeostasis and dysregulation of it can promote
disease. Highly regulated go/stop signals are required to
establish multiple checkpoints [reviewed in (2)] and the
EC is indeed a critical one. Its activation initiates the
inﬂammatory response by recruiting leukocytes into the dam-
aged tissue (1), therefore EC dysfunction contributes to the
development of a chronic inﬂammatory response or vascular
disease. Tumor necrosis factor a (TNF-a) is a potent pro-
inﬂammatory cytokine that triggers a strong endothelial
activation which results in an increased vascular permeability,
the hallmark of the inﬂammatory response. The biological
effects of TNF-a are achieved by activation of signaling
cascades that elicit a speciﬁc gene expression program. One
major signaling pathway involves nuclear factor-kB( N F - kB).
Activation of NF-kB/Rel transcription factors plays a cent-
ral role in the regulation of diverse cellular processes such as
inﬂammation, immune response, differentiation, proliferation,
apoptosis and cancer. The mammalian Rel family consists of
ﬁve members p65/RelA, RelB, c-Rel, p50 and p52 which can
form homo- and/or heterodimers. They are tightly controlled
by a family of inhibitory molecules (IkBs) comprising IkBa,
IkBb and IkBe, and the precursor molecules for p50 and p52,
p105 and p100, respectively. In resting cells, NF-kB is inact-
ive because of its association with IkB proteins. Thereby
NF-kB is retained in the cytoplasm and DNA binding is pre-
vented. Upon cytokine signaling, innate or adaptive immune
responses, or environmental stress NF-kB activation is initi-
ated (3). Signaling pathways converge at a multisubunit IkB
kinase complex that consists of two catalytic subunits IKK1/a
and IKK2/b, and the regulatory components NEMO/IKKg
and a newly identiﬁed protein ELKS (4,5). Mice deﬁcient of
IKK2 or NEMO lack cytokine-induced NF-kB activation (6).
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doi:10.1093/nar/gki836The ‘canonical’ IKKb- and IKKg-dependent signaling path-
way involves phosphorylation of the IkB proteins atconserved
serine residues in their N-terminal domain. Subsequently,
they are polyubiquitinated and degraded by the proteasome.
Released NF-kB translocates to the nucleus and binds
to cognate DNA motifs in target genes, regulating their
transcription.
The biological effects of IKK/NF-kB signaling depend on
transcriptional regulation of a network of genes that contain
NF-kB binding sites in their promoter or enhancer regions. To
date a large list of target genes has been identiﬁed (7) and in
endothelialcells wehave previouslyshown thatgeneticinhibi-
tion of NF-kBb yI kBa mutants or dominant negative IKKb
blocks endothelial activation by suppressing the expression of
NF-kB dependent genes(8).
In this report, we have investigated the requirement of the
IKK complex and NF-kB for the gene expression by perform-
ing gene proﬁling in a human microvascular endothelial cell
line after prolonged TNF-a stimulation. Our approach used
retroviral gene transfer to effectively transduce a constitutive
active version ofIKKboradominantnegativeIkBa,by which
the ‘canonical’ NF-kB pathway was modulated allowing a
ﬁne-tuned investigation of differential gene induction by
TNF-a. Our data indicates that the IKK/NF-kB cascade gov-
erns the long-term gene response to TNF-a of microvascular
endothelial cells and suggest that secondary transcriptional
responses involving other regulators are submitted to NF-kB
control in agreement with recent previous reports (9,10).
In addition we provide compelling evidence for a pro-
atherogenic program elicited by IKK/NF-kB signalosome in
ECs. The transcriptional regulation of a potentially key pro-
atherogenic gene, endothelial lipase (EL) by NF-kB fur-
ther supports the master role of this signaling pathway in
atherosclerosis.
MATERIALS AND METHODS
Cell culture
Human microvascular endothelial cell line-1 (HMEC-1) was
provided by V. Gehrke (Muenster, Germany). Primary human
umbilical vein endothelial cells (HUVEC) were obtained from
Clonetics (Cell Systems, Germany). Primary human saphena
vein endothelial cells (HSVEC) were provided by N. Marx
(Ulm, Germany). HMEC-1 were cultured in endothelial basal
medium (Clonetics) supplemented with 2% fetal bovine serum
(FBS), 1.0 mg/ml hydrocortisone, 10 ng/ml human epidermal
growth factor, 12 mg/ml bovine brain extract, 50 mg/ml gen-
tamicin and 50 ng/ml amphotericin B. For culture of HUVEC
and HSVEC medium was supplemented with 10% FBS.
Experiments were performed with primary cells in passage 4.
Cells were stimulated with human recombinant TNF-a
(40 ng/ml, a gift from Boeheringer-Ingelheim). Protein syn-
thesis inhibition was achieved by treatment of the cells with
cycloheximide (5 mg/ml, Sigma). The FNX amphotropic
retrovirus producers (G. Nolan, Stanford, CA) and NIH-3T3
cells were cultured in DMEM (Life Technologies) containing
10% FBS, 100 U/ml penicillin-streptomycin (PAN Systems,
Germany), 1% L-Glutamine (PAN Systems, Germany), 1%
non-essential aminoacids (PAN Systems, Germany) and
25 mM b-mercaptoethanol (Sigma).
Retroviral infection of endothelial cells
The pCFG5-IEGZ retroviral vectors encoding transdominant
IkBa (TD IkBa) or constitutively active IKK2 (CA IKK2),
have been described (8). Infected cells were selected with
200 mg/ml of Zeocin (Invitrogen) until all cells were GFP
positive. As HMEC-1 expressing the CA-IKK2 altered growth
characteristics over time, GFP positive cells were sorted 48 h
after infection by ﬂow cytometry using a FACSAria (Becton
Dickinson) and prepared immediately for the experiments.
Flow cytometry and protein analysis
Analysis of ICAM-1 expression was performed as described
(8). Flow cytometry experiments were repeated at least twice.
For western blot analysis, whole cell extracts were prepared
and analyzed as described (8). For analysis of periplakin
expression, 70 mg of protein extracts were separated on 5%
polyacrylamide gels and probed using antibodies against peri-
plakin (Santa Cruz). For EMSA, whole cell extracts (2–5 mg
protein) were incubated with radiolabeled double-stranded
oligonucleotides containing the Ig-k enhancer consensus kB
site (11) or putative kB sites from the endothelial lipase gene
(sequences available upon request). For supershift experi-
ments, 5 mg of protein extract were preincubated for 30 min
at room temperature with speciﬁc antibodies. And for com-
petition assays, protein extracts were pre-incubated with
non-labeled double-stranded oligonucleotides for 10 min at
room temperature. Protein synthesis inhibition by cyclo-
heximide treatment was controlled by metabolic cell labeling
with [
35S] Methionine (100 mCi/ml; Amersham Pharmacia
Biotech).
Microarray analysis
Atotalof4–5 · 10
6cells were stimulatedwith TNF-afor16h
or left untreated, harvested and frozen at  80 C. Cell pellets
were then processed at the IZKF Microarray Facility Tuebin-
gen (Tuebingen, Germany) where, the RNA preparation and
hybridization assay were performed according to the manufac-
turer’s instruction. Hybridization was done onto Affymetrix
Humane Genome Array Chip U133A. Data were processed
with Affymetrix Microarray Suite (MAS) Software 5.0 and
NetAFFX Analysis Center Tools (Affymetrix Inc. CA). Fur-
ther analyzes including Venn diagrams were performed using
GeneSpring (Silicon Genetics/Agilent) and VisualX was used
for graphical representations (available from hans.kestler@
medizin.uni-ulm.de upon request).
RT–PCR analysis
Total RNA was isolated using the High Pure RNA Isolation
Kit (Roche, Germany). cDNA was synthesized with M-MLV
reversetranscriptase(Promega,USA)andPCRwasperformed
using Taq DNA polymerase (Amersham Pharmacia Biotech,
USA). Primers sequences are available upon request.
Cloning and transient co-transfection assays
The genomic region spanning from  1381 to +240 of the
endothelial lipase gene [GenBank /EBI Data Bank Acces-
sion no. NM_006033.1, Gene ID 9388, LIPG] was ampliﬁed
with Pfx polymerase (Invitrogen) and inserted upstream of the
luciferase gene (50hLIPG) (primer sequences available upon
Nucleic Acids Research, 2005, Vol. 33, No. 16 5309request). The generation of reporter vectors for the putative
NF-kB binding sites in LIPG promoter was done by cloning a
synthetic oligonucleotide containing three copies of either the
distal site (3· -L1) or the proximal site (3· -L2) upstream of a
TATA-only promoter luciferase construct. All reporter vectors
were conﬁrmed by sequencing. Five mgof these constructs and
as a control 100 ng of b-actin renilla expression vector were
transiently co-transfected together with 15 mg of either RelA/
p65 expression vector or empty vector into NIH-3T3 cells.
Luciferase activities were measured after 36 h using the
Dual-Luciferase Reporter Assay System (Promega, USA).
Site directed mutagenesis
For mutagenesis of the distal kB site in the 50hLIPG vector,
a mutagenic primer (50-gagggagaagaggaggacaaagctcacgct-
caggtggctctcccccgacgg-30) was annealed to denaturate the par-
ental plasmid and extended by PCR using Pfx polymerase
(Invitrogene). Non-mutated DNA was removed by treatment
with DpnI endonuclease. Positive clones were sequenced to
conﬁrm the mutation and the integrity of the remaining
construct.
Chromatin immunoprecipitation assay (ChIP)
Chromatin immunoprecipitation (ChIP) was performed as
described previously (12). One mg of rabbit anti-RelA/p65
(sc-372, Santa Cruz) or rabbit anti-PLCg1 (sc-81, Santa
Cruz) were used. Samples were analyzed by PCR using spe-
ciﬁc primers for the appropriate regions (primer sequences
available upon request).
RESULTS
GeneticmanipulationofNF-kBactivityinHMEC-1cells
We wanted to investigate the role of the IKK/NF-kB signaling
pathway in the gene expression program of microvascular
endothelial cells under TNF-a stimulation. Retroviral gene
transfer was used to stably express the dominant interfering
mutants of the IKK/NF-kB pathway in the HMEC-1 cell line,
an establishedmicrovascular endothelialcelllinederived from
human dermal microvasculature (13). Suppression of NF-kB
signaling was achieved by using a trans-dominant IkBa
protein (TD-IkBa) with serine to alanine mutations in the
N-terminal domain. For selective activation of this pathway,
a constitutively active version of IKK2 (CA-IKK2) bearing
phosphomimetic serine to glutamate mutations in the activa-
tion loop was used (Figure 1A) (8,14,15). Consequences of the
expression of these NF-kB modulating proteins were then
analyzed in transduced cells. Whereas TNF-a induced rapid
degradation of endogenous IkBa in cells infected with empty
vector, the transdominant IkBa protein was stable under these
conditions (Figure 1B). Expression of the endogenous IkBa
protein was almost completely repressed in TD-IkBa infected
cells consistent with earlier ﬁndings (Figure 1B) (8,15). Fur-
thermore, stimulation of TD-IkBa-expressing cells failed to
induceNF-kBasdocumentedbyelectrophoreticmobility shift
assay (EMSA) experiments (Figure 1C). Importantly, expres-
sion of CA-IKK2 induced NF-kB DNA binding activity
already in the absence of TNF-a, which could be slightly
enhanced by treatment with TNF-a (Figure 1C). Competition
experiments using amutatedkB-probeconﬁrms the speciﬁcity
for NF-kB binding (Figure 1D). While supershift analyzes
with speciﬁc antibodies show that the DNA binding complex
is composed of p50/p65 proteins (Figure 1E).
We had previously seen that a similar modulation of NF-kB
activity in HUVEC cells affected the expression of various
chemokines and cell surface proteins (8). Therefore, we ana-
lyzed infected HMEC-1 cells before and after stimulation with
TNF-a for expression of ICAM-1 by FACS. Both parental
HMEC-1 and empty vector transduced HMEC-1 showed an
up-regulation of ICAM-1 (Figure 1F). The CA-IKK2 express-
ing cells showed strong ICAM-1 expression even without
TNF-a stimulation, whereas no ICAM-1 expression could be
induced in TD-IkBa cells (Figure 1F). Similar results were
obtained for interleukin-8 and MCP-1 (data not shown).
IdentificationofTNF-aregulatedgenesinHMEC-1cells
and dependence on the IKK/NF-kB pathway
These results encouraged us to perform a global analysis of
gene expression in response to TNF-a in these genetically
modiﬁed cells. Gene expression proﬁles were obtained from
three independent experiments using the Affymetrix Human
GenomeU133Aplatform.OurdeﬁnitionofaclassicalTNF-a-
induced NF-kB target gene was the following: NF-kB target
genes should be up-regulated in unstimulated HMEC-1 cells
expressing CA-IKK2 compared to empty vector control cells.
TNF-a stimulation might result in a further induction of these
genes in CA-IKK2 expressing cells. These genes should be
induced by TNF-a in empty vector infected cells, but not or
less induced in TNF-a stimulated HMEC-1 cells expressing
TD-IkBa. Corresponding criteria should hold for genes
repressed by NF-kB. In the subsequent analyzes we only con-
sidered genes whose expression was altered at least 2-fold
(SLR > 1) in a minimum of seven out of nine possible com-
binations between the triplicates of each comparison.
We identiﬁed 141 genes up-regulated by TNF-a in control
HMEC-1 (Figure 2A). CA-IKK2 induced expression of 162
genes whereas 199 entries corresponded to genes down-
regulated in TNF-a stimulated TD-IkBa cells when compared
to TNF-a-stimulated control cells. The above described cri-
teria were fully met by 106 genes which represent targets with
high probability to contain NF-kB regulatory elements within
their promoter/enhancerregions. Itbecame clearthatoutofthe
141genesinducedbyTNF-aincontrolcells,only6genes(4%
of the total) did not reveal evidence for an involvement of
classical NF-kB for transcriptional regulation. Expression of
27 genes was induced by TNF-a in control cells and was
decreased in TD-IkBa cells, yet they were not signiﬁcantly
increased in CA-IKK2 infected cells suggesting that NF-kBi s
not sufﬁcient and other pathways are required. Surprisingly,
49 genes were decreased in TNF-a stimulated HMEC-1 trans-
ducing TD-IkBa compared to stimulated HMEC-1 transduced
withthe emptyvector. This result might suggestarole ofIkBa
in gene regulation in addition to NF-kB inhibition. In this
respect, recent evidence shows that IkBa recruitment to the
hes1 promoter is associated with transcriptional repression
(16). At the same time, 37 genes showed up-regulation in the
presence of CA-IKK2 but they were not strongly induced
by TNF-a stimulation in control cells. This hints at functions
of IKK in addition to regulating NF-kB. Indeed, recent
5310 Nucleic Acids Research, 2005, Vol. 33, No. 16evidence suggests that IKK2 is involved in control of the
Foxo3a transcription factor (17).
Expression proﬁling results were highly consistent as
is evident from the representation shown in Figure 2B.
This Figure depicts the genes for which all predictions
described above were met. The ﬁve genes with the highest
TNF-a induced expression were ubiquitin D (average
89-fold), natural killer cell transcript 4 (NK4, average
Figure 1. Genetic manipulation of NF-kB transduced HMEC-1 cells. (A) Schematic representation of the retrovirus used for the expression of the IkBa and IKKb
mutants.IRES,internalribosomeentrysite;LTRlongterminalrepeat:Zeo,zeocinresistancegene;TD,transdominant;CA,constitutivelyactive.(B)Endothelialcells
stablyexpressingparentalvectorortransdominantIkBawerestimulatedwithTNF-aforthe timeintervalsindicated.IkBadegradationwasvisualizedbyWestern
blot analysis. (C) TNF-a-induced NF-kB DNA-binding activity was studied by EMSA. NF-kB complexes are indicated; ns, non-specific band. (D) Competition
EMSA.LabeledconsensuskBprobewasincubatedwith20minTNF-a-stimulatedorcontrolHMEC-1wholecellextractsinthepresenceofincreasingamountsof
coldprobes forconsensuskB-probe(specific)or mutatedkB-probe(non-specific).(E) Supershiftassay.Wholecell extracts of20 min TNF-a-stimulatedorcontrol
HMEC-1 were pre-incubated with specific antibodies before NF-kB DNA-binding activity was studied by EMSA. (F) Parental HMEC-1 or cells expressing TD
IkBa, CA IKK2 or empty vector, respectively, were stimulated for 16 h with TNF-a. Expression of ICAM was determined by FACS before (black line) or after
TNF-a stimulation (grey line).
Nucleic Acids Research, 2005, Vol. 33, No. 16 531162-fold induction), Epstein–Barr virus-induced gene 3 (EBI3,
average 54-fold), chemokine (C-C motif) ligand 5 (RANTES,
average36-fold)andchromosome1openreadingframe(ORF)
29 corresponding to hypothetical protein GS3686 (average
23-fold). These ﬁve genes are also highly regulated in HMEC-
1 expressing the active IKK2 mutant protein. In addition, CA-
IKK2 strongly induced expression of the bone marrow stromal
cell antigen 2, viperin, chemokine (C-X-C motif) ligand 5
(epithelial-derived neutrophil-activating peptide 78), chemo-
kine (C-X-C motif) ligand 11, baculoviral IAP repeat-
containing 3 and the myxovirus resistance 2 gene. All these
genes are also induced by TNF-a and repressed in TNF-a-
stimulated HMEC-1 transduced with TD-IkBa. Interestingly,
the gene proﬁle obtained reﬂects a pro-atherogenic program
induced by long-term TNF-a stimulation in ECs which
is strictly regulated by IKK/NF-kB signaling pathway.
5312 Nucleic Acids Research, 2005, Vol. 33, No. 16Figure2.IdentificationofTNF-aregulatedgenesanddependenceontheIKK/NF-kBpathway.HMEC-1linesexpressingTDIkBa,CAIKK2oremptyvectorwere
cultured to  80% confluence, stimulated with of TNF-a for 16 h and RNA expression profiles were determined by oligonucleotide array hybridization in three
independent experiments. Venn diagrams are depicted for (A) up-regulated genes and (C) down-regulated genes. In (B and D) the graphic representations of the
respective genes up- or down-regulated by TNF-a that fully meet the inclusion criteria are shown. For each gene the variation of the expression levels between the
three experiments is shown.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5313(The complete and detailed list of identiﬁed genes is provided
as Supplementary Data Set and will be submitted to MIAME).
TNF-a and CA-IKK2 not only induced gene expression but
also a number of genes were identiﬁed which are repressed by
these pathways. The corresponding Venn diagram represents
37 entries of genes down-regulated in control cells exposed
to TNF-a (Figure 2C). Furthermore, expression of 54 genes
decreased in CA-IKK2 cells, whereas 72 transcripts were
increased in TD-IkBa HMEC-1 when stimulated with
TNF-a compared to stimulated control cells. In contrast to
the extremely high overlap between TNFa-targets and NF-
kB-regulated genes observed for the induced genes, only 27%
of the genes down-regulated by TNF-a were affected by the
IKK/NF-kB interfering mutants. This indicates a wider spec-
trum of signaling pathways involved in gene repression by
TNF-a.
TNF-a induced gene expression by RT–PCR
We wanted to conﬁrm the differential expression pattern for a
subset of genes by semi-quantitative RT–PCR. In addition to
the analysis in the various HMEC lines, we also investigated
these targets in TNF-a-stimulated HUVEC and HSVEC. This
comparison allowed us to determine whether these selected
genes were regulated similarly in microvasculature- and
macrovasculature-derived endothelial cells and also allowed
us to estimate the impact of our experimental model in gene
expression. Five genes showing an induction between 5 fold
and more than 20 fold in the microarray experiments were
chosen: ubiquitin D (DUB), Epstein–Barr virus-induced
gene-3 (EBI3), vascular cell adhesion molecule-1 (VCAM),
endothelial lipase (LIPG) and galectin 9 (LGALS9)
(Figure 3A).
In agreement with the microarray data, TNF-a stimula-
tion increases mRNA levels of all genes investigated in
parental and empty vector transduced HMEC-1. The house-
keeping gene GAPDH was used as control. The same behavior
is observed for HUVEC and HSVEC when exposed to
TNF-a, despite some differences in basal expression levels
inunstimulatedcells.As expected,TD-IkBalargelyabolished
TNF-a-induced expression of the investigated genes in
HMEC-1 cells. In contrast, CA-IKK2 increased mRNA levels
of these genes and additional TNF-a-stimulation resulted in
only a minimal further increase. Therefore, IKK2 is sufﬁcient
to up-regulate expression of all genes investigated. Kinetic
analyzes revealed that VCAM and EBI3 show increased
expression between 1 and 2 h of TNF-a stimulation, whereas
expression-levels of LIPG and DUB started to increase after
4 h (Figure 3B).
TNF-a/NF-kB suppresses periplakin expression
Our screen had revealed a number of genes repressed by both
TNF-a and IKK2. We chose the best regulated of these genes,
periplakin, for a more detailed analysis. Expression proﬁling
had predicted a roughly 6- to 7-fold regulation and this was
conﬁrmed by RT–PCR (Figure 4A). Repression was even
more pronounced in HUVEC and HSVEC. Repression was
strongly attenuated when NF-kB induction was blocked by
TD-IkBa. CA-IKK2 virtually eliminated baseline expression.
Kinetic analyzes revealed that most of periplakin mRNA was
reduced between 5 and 8 h after TNF-a induction in HUVEC
and HMEC1, respectively (Figure 4B). No loss of periplakin
mRNA was detected when TD-IkBa was expressed. The
effect of NF-kB on TNF-a-induced repression of periplakin
is most likely direct as it is independent of de novo protein
synthesis as shown by the analysis of periplakin expres-
sion after pre-treatment of the cells with cycloheximide
(Figure 4C). The efﬁciency of protein synthesis inhibition
by cycloheximide was larger than 90% conﬁrmed by in vivo
[35S]-methionine cell-labeling (data not shown). Finally,
western blot analysis showed periplakin down-regulation in
parental HMEC-1 after TNF-a-stimulation, whereas cells
expressing TD-IkBa showed no decrease at the protein
level (Figure 4D).
The endothelial lipase gene contains functional
NF-kB sites
A known predisposing factor in the development of athero-
sclerosis is a change in high density lipoprotein (HDL) versus
Figure 3. Analysis of TNF-a-induced gene expression in two additional
endothelial models by RT–PCR. (A) Total RNA from HMEC-1 lines and
primary HUVEC and HSVEC stimulated with TNF-a for 16 h was used for
cDNA preparation and RT–PCR analysis. Specific primers for the indicated
geneswereused.(B),KineticofTNF-a-inductionofdifferentmRNAsinempty
vector infected HMEC-1 is shown.
5314 Nucleic Acids Research, 2005, Vol. 33, No. 16low density lipoprotein (LDL) levels. The endothelial lipase
(gene nomenclature LIPG) identiﬁed in our gene screening is
of speciﬁc interest in this respect due to its role in HDL
metabolism. This recently cloned new member of the lipase
family of proteins catabolizes HDL and it is the only lipase
member secreted by endothelial cells (18,19). Endothelial
lipase is induced by inﬂammatory cytokines but clear
NF-kB dependence has not been demonstrated (20). Due to
the potential role of this gene as predisposing factor for lipid
metabolism-related diseases a more detailed promoter analysis
was performed. The gene encoding endothelial lipase is loc-
ated on chromosome 18. It consists of 10 exons and 9 introns.
A TATA box was predicted between  30 and  22. Two kB
sites were predicted in the 50 region at  467 (proximal) and at
 1250 (distal) (Figure 5A). NF-kB-binding to these sites was
analyzed by EMSA. The distal site showed strong NF-kB-
binding (Figure 5B), whereas the proximal site showed only
weak NF-kB-binding. Supershift analyzes conﬁrmed the
binding of RelA/p65 to both putative kB sites (Figure 5C).
Moreover, when a labeled consensus kB probe was incubated
with stimulated HMEC-1 protein extracts in the presence
of increasing amounts of oligonucleotides corresponding
to the putative kB sites in endothelial lipase gene, strong
competition for NF-kB binding was seen for the distal
site, while the proximal site competed to a lesser extent
(Figure 5D).
TNF-a induces recruitment of RelA/p65 to the
endothelial lipase promoter
To determine whether inducible NF-kB-binding to the LIPG
promoter could be observed in vivo, we performed ChIP.
HMEC-1 cells were stimulated with TNF-a for 4 h and
formaldehyde-cross linked chromatin was precipitated with
an anti-RelA/p65 antibody. As a negative control an irrelevant
antibody (anti-PLCg1) was used (Figure 6A). The binding of
RelA/p65 to the IkBa and RANTES promoters served as
positive control. ChIP-analysis of these control genes revealed
TNF-a-inducible RelA/p65 recruitment to the respective pro-
moters as expected. Interestingly, inducible recruitment of
RelA/p65 was detectable at the distal site of the LIPG pro-
moter (Figure 6A) while only a weak induction was observed
at the proximal site (data not shown).
Figure 4. TNF-a down-regulates periplakin expression in HMEC-1, HUVEC
and HSVEC. (A) Total RNA from HMEC-1 lines and primary HUVEC and
HSVEC stimulated with TNF-a for 16 h was used for cDNA preparation and
RT–PCR analysis. (B) Time course of periplakin mRNA down-regulation in
response to TNF-a. HMEC-1 stably expressing the empty vector or transdo-
minant IkBa, or HUVEC were stimulated with TNF-a for the indicated inter-
vals, total RNA was analyzed by RT–PCR. (C) Expression level of periplakin
was analyzed after TNF-a stimulation in the presence of cycloheximide. Con-
fluent cells were pre-incubated with vehicle or cycloheximide (CHX) for 1 h
and then treated with TNF-a or medium for 8 h. (D) Western blot analysis for
periplakin (195 kDa). Parental or TD-IkBa transduced HMEC-1 were stimu-
lated with TNF-a for 16 h and whole protein extracts were probed with a
periplakin-specific antibody ˜. RelA/p65 was used as loading control.
Figure 5. The endothelial lipase gene contains functional NF-kB sites.
(A)SchematicrepresentationofputativeNF-kBbindingsitesintheendothelial
lipase (LIPG) gene. (B) TNF-a-induced NF-kB DNA-binding to putative kB
sites in the LIPG gene was studied by EMSA. (C) Supershift assay. Whole cell
extracts of 1 h TNF-a-stimulated or control HMEC-1 were pre-incubated with
specific antibodies before NF-kB DNA-binding activity to putative kB-sites
was studied. (D) Competition EMSA. Labeled consensus kB probe was
incubated with 1 h TNF-a-stimulated or control HMEC-1 extracts in the pre-
sence of increasing amounts of cold probes for the putative kB sites.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5315Finally we wanted to demonstrate the direct regulation of
the LIPG promoter by NF-kB in reporter co-transfection
experiments. To achieve these experiments we used NIH-
3T3 cells, since HMEC-1 cells were completely resistant to
transient transfection. A promoter fragment encompassing the
region from  1381 to +240 was cloned upstream of a luci-
ferase reporter gene (Figure 6B). This promoter fragment,
named 50hLIPG, contained both the distal and the proximal
kB sites. When this reporter was co-transfected with RelA/p65
expression vector in NIH-3T3 cells we indeed observed an
induction of 6 fold in the luciferase activity. The mutation of
the perfect distal kB-motif results in a reduction of RelA/
p65-induction in 50% (Figure 6B). In addition, we have gen-
erated luciferase reporter constructs that contain three copies
Figure 6. TNF-a-induced expression of endothelial lipase is associated with recruitment of RelA/p65 to the distal kB site. (A) Binding of RelA/p65 to regulatory
regions of LIPG, RANTES and IkBa in HMEC-1 after stimulation with TNF-a for 4 h was detected by ChIP assay. Negative controls were chromatin samples to
which no antibody was added (w/o Ab) or immunoprecipitated with anti-PLC-g1 antibody. DNA purified from the lysates incubated without antibody was used as
inputcontrol(Input).Allexperimentswere performedatleast in duplicates.(B) LIPGpromoterfragmentencompassingtheregionfrom 1381to +240 wascloned
upstream of a luciferase reporter gene. The resultant vector named 50hLIPG was transiently co-transfected into NIH-3T3 cells together with a RelA/p65 expression
vector or an empty vector as control. Site directed mutagenesis to the distal kB-site of 50hLIPG resulted in the modified reporter vector named 50hLIPGDL1, which
was transiently co-transfected into NIH-3T3 cells together with a RelA/p65 expression vector or an empty vector as control. (C) Luciferase reported vectors
containingthreecopiesofLIPG-kBdistal(3x-L1)andproximal(3x-L2)sitesweretransientlyco-transfectedintoNIH-3T3cellswithRelA/p65expressionvectoror
emptyvectorascontrol.AluciferasevectorcontainingthreecopiesofthekB-motifwasusedaspositivecontrol.Luciferaseactivitiesweremeasuredafter24h.All
experiments were performed at least in duplicates.
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stream of a TATA-only promoter. These synthetic reporters
are both responsive to RelA/p65 co-transfection in NIH-3T3
cells. However, a stronger induction of luciferase is achieved
by the distal motif in comparison to the proximal kB-site
(Figure 6C).
DISCUSSION
The induction of gene expression by TNF-a is known to
critically depend on activation of MAPK and IKK signaling.
The ﬁrst pathway involves phosphorylation of ERKs, JNKs
and p38 members and the subsequent activation of transcrip-
tion factors like Elk-1, AP-1, SRF or CREB, whereas the IKK
pathway induces activation of NF-kB. Thus, it is expected that
endothelial gene proﬁle after long-term TNF-a stimulation
should reﬂect the activation of the given range of signaling
cascades. Yet, our gene expression proﬁle suggests that
the IKK/NF-kB signalosome plays the dominant role in
TNF-a-induced activation of HMEC-1 cells. Almost all
TNF-a-induced genes in control HMEC-1 were repressed
in TD-IkBa transducing cells (94%), while the 76% of
them were already up-regulated in CA-IKK2 infected cells
in the absence of stimulation. A total of 106 genes equivalent
to the 75% of the TNF-a-induced proﬁle were transcription-
ally controlled by CA-IKK2 and TD-IkBa. This group of
genes represents the vast majority of TNF-a-response genes
and the classical IKK/NF-kB signaling module is sufﬁcient to
regulate their expression probably by direct NF-kB regulatory
elements in their promoter/enhancer regions.
In our study TNF-a induction of only few genes was
partially or completely independent of classical IKK/NF-kB
activation. The group of genes that were induced by TNF-a,
repressed by TD-IkBa but not up-regulated by CA-IKK2 is
of particular interest. Their transcriptional regulation requires
NF-kB but NF-kB is not sufﬁcient, suggesting that other regu-
lators are necessary. TNF-a-induced IKK/NF-kB-independ-
ent mechanisms could involve the MAPK/AP-1 pathway. A
previous report analyzed the contribution of p38-MAPK in the
gene expression proﬁle of HUVEC after 5 h TNF-a stimula-
tion and determined that a minor number of genes underlie
additional control by this pathway (10). Using the p38-MAPK
inhibitor SB202190 they observed that the TNF-a-dependent
up-regulation of the gene C1orf4 was totally inhibited. In our
screen, TNF-a induction of this gene was comparable to the
extent observed by the previous authors, but at the same time
TD-IkBa was able to completely suppress this induction.
In the same study, the IKK2-dependent induction of other
genes suchasIL8, VCAM, inhibinbetaorGBP-1 waspartially
repressed ( 50%) by SB202190. According to our genechip
data, these genes fully met the inclusion criteria and deﬁnition
of a NF-kB target, showing complete repression by TD-IkBa.
It has been proposed that p38-MAPK activity is required to
enhance the accessibility of RelA/p65 for recruitment to a
subset of genes activated in cells exposed to inﬂammatory
stimuli in a promoter-speciﬁc manner (21). This mechanism
could explain the enhanced expression observed in these
NF-kBtargetsbyp38-MAPK. Another interesting observation
is the regulation of ubiquitin D. Viemman et al. (10) showed
that the strong induction of this gene by TNF-a was
completely inhibited in the presence of SB202190. In our
genechip analysis this gene showed the strongest up-
regulation by TNF-a and repression by TD-IkBa whereas
CA-IKK2 induction did not reach the extent of TNF-a.I n
addition, the semi-quantitative RT–PCR revealed the com-
plete absence of this mRNA in HMEC-1 transduced with
TD-IkBa and stimulated by TNF-a at different time intervals
(data not shown), suggesting an absolute dependence on the
IKK/NF-kB module. Our results together with those presented
by Viemman et al. (10) indicates that ubiquitin D expression
requiressynergisticactivationofIKK/NF-kBandp38-MAPK,
and that both pathways are essential.
Recently, Krappman et al. investigated to a deeper extent
the cross-talk between NF-kB and AP-1 transcription factors
in the LPS-induced gene expression in precursor B cells (9).
Their results indicated that NF-kB mounts the secondary tran-
scriptional response to LPS involving the control of AP-1
activation. In our experimental model, long-term TNF-a
stimulation, was used to mimic a pathophysiological condi-
tion. This prolonged activation of the EC, might enable NF-kB
to evoke a transcriptional response in cooperation with AP-1
signaling for e.g. or with pathways such as JAK/STAT activ-
ated by autocrine sources like IL-6. However, further analyzes
are neededto deﬁne the integration rolethat NF-kBmight play
to orchestrate the inﬂammatory program elicited by TNF-a
in ECs.
TNF-a stimulation also represses transcription. The
analysis of periplakin, the gene that showed the strongest
down-regulation by TNF-a and fully met our inclusion cri-
teria, suggests a direct transcriptional repression mechanism
by NF-kB. The mechanisms by which NF-kB down-regulates
transcription appear to be diverse and are not fully understood
yet (22). In a recent report, it was proposed that RelA/p65
directly represses transcription of antiapoptotic genes by a
mechanism that involves a differential phosphorylation of
RelA/p65, which regulates its ability to interact with corepres-
sors such as histone deacetylase (23). In addition to direct
repression, it was also proposed that NF-kB affects Sox9
and MyoD expression by an indirect mechanism involving
mRNA destabilization (24).
A second goal of our study was to investigate the NF-kB
dependence of genes with a link to atherogenesis. Given
the current appreciation that inﬂammatory mechanisms are
coupled to atherogenesis (25) we were eager to deﬁne the
role of TNF-a-induced endothelial gene program in this
process.
NF-kB target genes could be classiﬁed in different func-
tional groups. Those with a primarily inﬂammatory function
were predominant. Genes for monocyte, macrophage, neutro-
phil and T-cell chemoattractant chemokines and cytokines
(RANTES, CCL20, CXCL3, CXCL2, CXCL11, CXCL5,
MCP-1, IL8 and GM-CSF) were up-regulated consistent
with the critical role of the endothelium in promoting leuko-
cyte inﬁltration. Interestingly, the EBI-3 gene showed the
strongest up-regulation among the regulated cytokines. In
particular, the product of this gene is a 34 kDa secreted
glycoprotein with important immunomodulatory functions
which has been implicated in chronic inﬂammatory diseases
(26–28). Up-regulation of these chemokines indeed high-
lights the active role of the endothelium in atheroma
formation.
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playacriticalroleinatherogenesis.Severalgenes belongingto
this group were up-regulated, e.g. Cathepsin S (CTSS). CTSS
is one of the most potent mammalian elastases. It is overex-
pressed in atherosclerotic lesions (29) and CTSS-deﬁciency
attenuates atherosclerosis in LDLR
 /  mice (30).
Up-regulation of matrix metalloproteinases MMP-10 and
MMP-12 further suggest an active role of the endothelium
in ECM-remodeling and potentially plaque instability.
MMP-12 has been associated with atherosclerosis (31). We
found expression of these MMPs affected by TD-IkBa, but
not by CA-IKK2, indicating that NF-kB is essential but not
sufﬁcient for their transcription. Taken together, the up-
regulation of these proteases modulates vascular permeability
and remodeling, leukocyte transmigration and ECM integrity.
These features are critical for initiation, maintenance and
resolution of atherosclerosis.
To analyze the NF-kB-dependence of genes with a func-
tional role in atherogenesis we investigated more in detail the
promoter of endothelial lipase (LIPG), a gene that fully met
our inclusion criteria and that is implicated in HDL metabol-
ism. LIPG is a new member of the triglyceride lipase family
expressed in endothelial cells (18,19). Both acute and chronic
inﬂammatory states are associated with decreased levels of
HDL-cholesterol and LIPG could play an important role in
this process. Recent ﬁndings revealed that inhibition of the
endothelial lipase gene resulted in a 50% increase in HDL-
cholesterol levels inmice (32). LIPGdirectly mediates cellular
lipoprotein uptake (33) and apoE knockout animals also tar-
geted at the LIPG locus show lower levels of atherosclerosis
(34). In our gene proﬁle, TNF-a stimulation resulted in a
10-fold induction of LIPG mRNA levels while CA-IKK2
induced its expression in 6-fold. RT–PCR analysis validated
these results and conﬁrmed the induction of gene expression in
two primary endothelial cell models. Two putative NF-kB
binding sites were predicted in LIPG 50-ﬂanking region. Res-
ults from EMSA, ChIP assays and co-transfection experiments
suggest regulation of LIPG by NF-kB. Moreover, mutation
analysis of the putative distal kB-site in the LIPG pomoter
and experiments with synthetic luciferase reporter vectors
containing either the distal or the proximal site give further
evidence of the direct contribution of these sites in the tran-
scriptional regulationof endothelial lipase. However, although
the proximal site shows a weaker response to RelA, it might
still contribute to the overall NF-kB response of the LIPG
promoter. This could explain the incomplete inhibition of
the 50hLIPGDL1 construct.Furtherstudies are needed to deter-
mine whether the induced expression of LIPG in endothelial
cells directly contributes to the development of atherosclerotic
plaques.
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